31 related articles for article (PubMed ID: 2367061)
1. Surgically resected brain tumors from 2015 to 2020.
Ge H; Yan Z; Chen J; Liu Y
Asian J Surg; 2024 Apr; 47(4):2019-2020. PubMed ID: 38220532
[No Abstract] [Full Text] [Related]
2. A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors.
Godlewski A; Czajkowski M; Mojsak P; Pienkowski T; Gosk W; Lyson T; Mariak Z; Reszec J; Kondraciuk M; Kaminski K; Kretowski M; Moniuszko M; Kretowski A; Ciborowski M
Sci Rep; 2023 Jul; 13(1):11044. PubMed ID: 37422554
[TBL] [Abstract][Full Text] [Related]
3. Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.
Aguiar PH; Tsanaclis AM; Tella OI; Plese JP
Neurosurg Rev; 2003 Jul; 26(3):221-8. PubMed ID: 12690530
[TBL] [Abstract][Full Text] [Related]
4. Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.
Dolbeare F
Histochem J; 1995 Dec; 27(12):923-64. PubMed ID: 8789396
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
Rice CD; Merchant RE
J Neurooncol; 1992 May; 13(1):43-55. PubMed ID: 1613537
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry in the diagnosis of brain tumors.
Rabson AR
Neurosurg Clin N Am; 1994 Jan; 5(1):135-46. PubMed ID: 8124088
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Maeda T; Hoshino T
No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Hoshino T; Ito S; Asai A; Shibuya M; Prados MD; Dodson BA; Davis RL; Wilson CB
Int J Cancer; 1992 Jan; 50(1):1-5. PubMed ID: 1728598
[TBL] [Abstract][Full Text] [Related]
10. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
[TBL] [Abstract][Full Text] [Related]
11. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.
Shibuya M; Hoshino T; Ito S; Wacker MR; Prados MD; Davis RL; Wilson CB
Neurosurgery; 1992 Apr; 30(4):494-7; discussion 497-8. PubMed ID: 1584346
[TBL] [Abstract][Full Text] [Related]
12. Cell-kinetic characteristics of human brain tumors.
Assietti R; Butti G; Magrassi L; Danova M; Riccardi A; Gaetani P
Oncology; 1990; 47(4):344-51. PubMed ID: 2367061
[TBL] [Abstract][Full Text] [Related]
13. Cell kinetics of glial tumors.
Hoshino T
Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
